CLDN4 and ovarian cancer: Together, these responses suggest that claudin-4 overexpression enhances control over the cell cycle in ovarian cancer cells by slowing progression through the S-phase and ensuring proper entry and exit from the G2–M phase toward the G0–G1 phase (Fig. 1D), potentially mitigating factors that could lead to genomic instability.